Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis

Abstract Background Paclitaxel dose-dense regimen has been controversial in clinical trials in recent years. This systematic review and meta-analysis tried to evaluate the efficacy and safety of paclitaxel dose-dense chemotherapy in primary epithelial ovarian cancer. Methods An electronic search fol...

Full description

Bibliographic Details
Main Authors: Wenjian Gong, Ruidi Yu, Canhui Cao, Yong Fang, Xuejiao Zhao, Qinglei Gao
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Journal of Ovarian Research
Subjects:
Ovarian cancer
Paclitaxel
Carboplatin
Dose-dense regimen
Online Access:https://doi.org/10.1186/s13048-023-01216-z

Internet

https://doi.org/10.1186/s13048-023-01216-z

Similar Items